Search Results

There are 23640 results for: content related to: Attenuation of islet-specific T cell responses is associated with C -peptide improvement in autoimmune type 2 diabetes patients

  1. You have free access to this content
    Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 10, October 2015, Pages: 999–1024, Xiao-Wu Chen, Zhi-Xu He, Zhi-Wei Zhou, Tianxin Yang, Xueji Zhang, Yin-Xue Yang, Wei Duan and Shu-Feng Zhou

    Version of Record online : 15 SEP 2015, DOI: 10.1111/1440-1681.12455

  2. You have free access to this content
    Effects of UCP2 –866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes

    British Journal of Clinical Pharmacology

    Volume 68, Issue 1, July 2009, Pages: 14–22, Min Yang, Qiong Huang, Jing Wu, Ji-Ye Yin, Hong Sun, Hai-Ling Liu, Hong-Hao Zhou and Zhao-Qian Liu

    Version of Record online : 5 MAY 2009, DOI: 10.1111/j.1365-2125.2009.03431.x

  3. Effects of the Peroxisome Proliferator Activated Receptor-γ Coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser Polymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus

    The Journal of Clinical Pharmacology

    Volume 50, Issue 9, September 2010, Pages: 1022–1030, Ke-Han Zhang, Qiong Huang, Xing-Ping Dai, Ji-Ye Yin, Wei Zhang, Gan Zhou, Hon G-Hao Zhou and Zhao-Qian Liu

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009355159

  4. You have free access to this content
    Abstract

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue S3, August 2016, Pages: 3–679,

    Version of Record online : 24 AUG 2016, DOI: 10.1002/pds.4070

  5. You have free access to this content
    Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue S1, September 2015, Pages: 1–587,

    Version of Record online : 25 SEP 2015, DOI: 10.1002/pds.3838

  6. You have free access to this content
    Clinical presentation and treatment of type 2 diabetes in children

    Pediatric Diabetes

    Volume 8, Issue s9, December 2007, Pages: 16–27, Orit Pinhas-Hamiel and Phil Zeitler

    Version of Record online : 6 NOV 2007, DOI: 10.1111/j.1399-5448.2007.00330.x

  7. Posters

    Diabetic Medicine

    Volume 23, Issue s4, December 2006, Pages: 265–410,

    Version of Record online : 7 NOV 2006, DOI: 10.1111/j.1464-5491.2006.02037_13.x

  8. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes

    Diabetes/Metabolism Research and Reviews

    Volume 24, Issue 4, May/June 2008, Pages: 257–285, Patrick J. Boyle and John Zrebiec

    Version of Record online : 30 JAN 2008, DOI: 10.1002/dmrr.795

  9. You have free access to this content
    Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 11, November 2013, Pages: 967–977, A. Consoli and G. Formoso

    Version of Record online : 18 APR 2013, DOI: 10.1111/dom.12101

  10. You have free access to this content
    Diabetes and obesity: therapeutic targeting and risk reduction – a complex interplay

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 4, April 2010, Pages: 267–287, Kevin Niswender

    Version of Record online : 6 NOV 2009, DOI: 10.1111/j.1463-1326.2009.01175.x

  11. You have free access to this content
    Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes

    British Journal of Pharmacology

    Volume 172, Issue 3, February 2015, Pages: 721–736, Mitchel Tate, Aaron Chong, Emma Robinson, Brian D Green and David J Grieve

    Version of Record online : 1 DEC 2014, DOI: 10.1111/bph.12943

  12. You have free access to this content
    Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 2, February 2015, Pages: 125–138, Zhi-Xu He, Zhi-Wei Zhou, Yinxue Yang, Tianxin Yang, Si-Yuan Pan, Jia-Xuan Qiu and Shu-Feng Zhou

    Version of Record online : 12 JAN 2015, DOI: 10.1111/1440-1681.12332

  13. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 12, December 2008, Pages: 1204–1211, Y. Miyazaki and R. A. DeFronzo

    Version of Record online : 12 MAY 2008, DOI: 10.1111/j.1463-1326.2008.00880.x

  14. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 1, January 2015, Pages: 27–32, Jin-Fang Song, Tao Wang, Jing Zhu, Xue-Yan Zhou, Qian Lu, Hao Guo, Fan Zhang, Yan Wang, Wei Li, Dan-Dan Wang, Ya-Wen Cui, Dong-Mei Lv and Xiao-Xing Yin

    Version of Record online : 22 DEC 2014, DOI: 10.1111/1440-1681.12314

  15. You have free access to this content
    Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue s3, August 2012, Pages: 1–481,

    Version of Record online : 27 AUG 2012, DOI: 10.1002/pds.3324

  16. Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue S1, October 2014, Pages: 1–497,

    Version of Record online : 30 SEP 2014, DOI: 10.1002/pds.3701

  17. You have free access to this content
    Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 63, Issue 5, May 2007, Pages: 562–574, Martijn Van Doorn, Jack Vogels, Albert Tas, Ewoud Jan Van Hoogdalem, Jacobus Burggraaf, Adam Cohen and Jan Van Der Greef

    Version of Record online : 24 NOV 2006, DOI: 10.1111/j.1365-2125.2006.02816.x

  18. You have free access to this content
    Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 62, Issue 4, October 2006, Pages: 391–402, Martijn Van Doorn, Michiel Kemme, Margriet Ouwens, Ewoud J. Van Hoogdalem, Richard Jones, Hans Romijn, Marieke De Kam, Rik Schoemaker, Koos Burggraaf and Adam Cohen

    Version of Record online : 7 NOV 2005, DOI: 10.1111/j.1365-2125.2005.02532.x

  19. Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

    Journal of Evidence-Based Medicine

    Volume 8, Issue 3, August 2015, Pages: 134–148, Yue-hong Chen, Liang Du, Xing-yuan Geng, Yuan-ling Peng, Jia-ni Shen, Yong-gang Zhang, Guan-jian Liu and Xin Sun

    Version of Record online : 21 SEP 2015, DOI: 10.1111/jebm.12157

  20. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 2, August 2015, Pages: 145–161, CA Alvarez, I Lingvay, V Vuylsteke, RL Koffarnus and DK McGuire

    Version of Record online : 3 JUL 2015, DOI: 10.1002/cpt.143